In an effort to support global initiatives to contain the spread of the new coronavirus (COVID-19), the Academy is presenting Spring 2020 events through online platforms and some of our previously scheduled events are being postponed to a later date. Please check our events listing for the latest information and contact our Customer Service team with any additional questions. For Academy programs and resources about COVID-19, click here.

We are experiencing intermittent technical difficulties. At this time, you may not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

This site uses cookies.
Learn more.

×

This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

Annals

Pharmaceutical Science to Improve the Human Condition: Prix Galien 2010

Pharmaceutical Science to Improve the Human Condition: Prix Galien 2010

Published: March 2011

Volume 1222

This Annals volume includes scholarly summaries of scientific achievement by winners and finalists candidates of the 2010 Prix Galien USA, Prix Galien International, and Prix Galien Pro Bono Humanitarian Awards.
Learn More

This Annals volume presents the scientific and humanitarian achievements by winners and finalists candidates of the 2010 Prix Galien USA, Prix Galien International, and Prix Galien Pro Bono Humanitarian Awards. Contributions include scholarly summaries from the biopharmaceutical industry leaders (Luminex, Merck, Novartis, Amgen, Bayer, Abbott, Centocor, Pfizer, Actelion, Servier, and Celgene) and remarks from the esteemed Pro Bono Humanitarian award winners William J. Clinton and Dr. Philippe Douste-Blasy, and an introduction by Secretary-General of the United Nations Ban Ki-moon. Winners and select finalists of the 2010 Prix Galien prizes represent the best in biotechnical and humanitarian achievements necessary to combat a wide range of diseases and issues affecting human health and well-being.